The CoviTact trial aims to collect saliva samples from COVID positive and negative patients in order to evaluate a new assay developed to detect the presence of SARS-COVID 2.

Samples are collected as part of ongoing studies and will be tested using the novel assay and via PCR.

Status: active

Start Date


Main Trial Site

Royal Infirmary of Edinburgh